|
⚲
|
| Keyboard |
| Gaston-Dreyfus Remi
✚
|
|
|---|---|
| CIK # | 0001716639 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001716639] | |
| 4 | [0001716639] | |
| SC 13D | [0001716639] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Gaston-Dreyfus Remi | Bionik Laboratories Corp | [2018-05-08] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gaston-Dreyfus Remi | |
| Bionik Laboratories Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bionik Laboratories Corp BNKL
Common Stock, par value $0.001 per share
|
2023-06-13 | Conversion | 3,102,878 | $0.60 | 1,861,727 |
|
Bionik Laboratories Corp BNKL
Common Stock, par value $0.001 per share
|
2023-06-09 | Buy | 180,555 | $0.60 | 108,333 |
|
Bionik Laboratories Corp BNKL
Common Stock, par value $0.001 per share
|
2022-03-31 | Conversion | 77,887 | $9.50 | 739,926 |
|
Bionik Laboratories Corp BNKL
Common Stock, par value $0.001 per share
|
2021-07-15 | Option exercise | 5,000 | ||
|
Bionik Laboratories Corp BNKL
Common Stock, par value $0.001 per share
|
2021-07-15 | Option exercise | 115,759 | ||
|
Bionik Laboratories Corp BNKL
Stock Option (right to buy) · derivative
|
2021-07-15 | Option exercise | 5,000 | $0.00 | |
|
Bionik Laboratories Corp BNKL
Stock Option (right to buy) · derivative
|
2021-07-15 | Option exercise | 115,759 | $0.00 | |
|
Bionik Laboratories Corp BNKL
Common Stock, par value $0.001 per share
|
2021-03-29 | Grant | 61,256 | ||
|
Bionik Laboratories Corp BNKL
Common Stock, par value $0.001 per share
|
2021-03-26 | Buy | 135,560 | ||
|
Bionik Laboratories Corp BNKL
Exchangeable Shares · derivative
|
2019-11-25 | Conversion | 4,997 | $0.00 | |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2019-11-25 | Conversion | 4,997 | $0.00 | |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2019-09-30 | Conversion | 76,225 | $6.80 | 518,330 |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2019-08-26 | Buy | 106,358 | $3.76 | 399,906 |
|
Bionik Laboratories Corp BNKL
Employee Stock Option (right to buy) · derivative
|
2019-07-26 | Grant | 115,759 | $0.00 | |
|
Bionik Laboratories Corp BNKL
Employee Stock Option (right to buy) · derivative
|
2019-05-31 | Grant | 5,000 | $0.00 | |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2019-03-28 | Conversion | 197,234 | $3.89 | 767,240 |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2018-07-24 | Conversion | 43,468,547 | $0.05 | 2,173,427 |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2018-06-13 | Conversion | 15,740,728 | $0.06 | 944,444 |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2018-03-31 | Conversion | 12,266,240 | $0.06 | 735,974 |
|
Bionik Laboratories Corp BNKL
Common Stock
|
2018-03-31 | Conversion | 63,197,149 | $0.06 | 3,791,829 |
| showing 20 of 23 most recent transactions | |||||